Sinovac Launches Seasonal Influenza Vaccine Anflu(R) for 2008-2009 ...(e the latest technology Sinovac hasintro...)

Date:9/10/2008

e the latest technology, Sinovac has introduced new insulation packaging to facilitate vaccine distribution. Based on customer feedback, the packaging features color-coded insulated packaging that effectively utilizes ice to maintain the desired temperature. The updated packaging enables the shipping of 50 or 100 doses.

Mr. Weidong Yin, Chairman, President and CEO, commented, "We are very pleased to launch Anflu(R) in China for the 2008 - 2009 seasonal influenza season. By utilizing our state-of-the-art production capability, we are well positioned to deliver our adult dosage formulation to our target market in China."

About Sinovac

Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases. Sinovac's commercialized vaccines include Healive(R) (hepatitis A), Bilive(R) (combined hepatitis A and B), Anflu(R) (influenza) and Panflu(TM) (H5N1). Sinovac is currently developing Universal Pandemic Influenza vaccine and Japanese encephalitis vaccine. Additional information about Sinovac is available on its website, http://www.sinovac.com . To be added to our distribution list, please email: info@sinovac.com.

Safe Harbor Statement

This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by words or phrases such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Among other things, the business outlook and quotations from management in this press release contain forward-looking statements. Statements that are not historical facts, including statements about Sinovac's beliefs and expec
'/>"/>

SOURCE Sinovac Biotech Ltd. Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related biology technology :

1. Sinovac Adjourns Annual General Meeting
2. Sinovac to Present at the Susquehanna Financial Groups Second Annual Beijing Management Summit Conference
3. Sinovac Reports Record Second Quarter 2008 Unaudited Financial Results
4. Sinovac Biotech Ltd. Schedules 2007 Annual Meeting of Shareholders
5. Sinovac Receives Healive(R) and Bilive(R) Purchase Orders from Provincial CDCs for Earthquake Disaster Areas
6. Sinovac Receives RMB 20 Million Purchase Order for Healive from Chinas Ministry of Health to Vaccinate Earthquake Victims
7. Sinovac to Present at the Brean Murray, Carret & Co. All-Cap All-China Conference and the Roth China Discovery Tour 2008
8. Sinovac Biotech Holds Annual General Meeting
9. Sinovac Reports Fourth Quarter and Full Year 2007 Financial Results
10. Sinovac to Host Conference Call to Report Fourth Quarter and Full Year 2007 Financial Results
11. Sinovac Announces Adjournment of Annual General Meeting